Quality of Malaria Treatment in Kenyan Children
Author Information
Author(s): Zurovac D, Njogu J, Akhwale W, Hamer D H, Snow R W
Primary Institution: KEMRI/Wellcome Trust Research Programme
Hypothesis
How effectively is artemether-lumefantrine being implemented in pediatric malaria treatment in Kenya?
Conclusion
The implementation of artemether-lumefantrine for treating malaria in children is inconsistent, with many children not receiving the recommended treatment.
Supporting Evidence
- 89% of facilities stocked artemether-lumefantrine.
- Only 26% of children needing treatment received artemether-lumefantrine.
- Health workers with in-service training were more likely to prescribe the correct treatment.
Takeaway
This study looked at how well doctors in Kenya are giving the right medicine to kids with malaria. Many kids didn't get the medicine they needed.
Methodology
Cross-sectional survey at all government facilities in four Kenyan districts.
Potential Biases
Potential bias due to self-reported data from health workers and caretakers.
Limitations
The study only evaluated practices 4-6 months after the new treatment policy was implemented, which may not reflect long-term adherence.
Participant Demographics
Children under 5 years of age presenting with fever or history of fever.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website